Back to search

Switzerland· 68315003

abnobaVISCUM Fraxini 0,2 mg, anthroposophisches Arzneimittel

A other plant alkaloids and natural products product, registered in Switzerland by Future Health Pharma GmbH and dispensed under Swissmedic category A.

Cat A (Swissmedic)ATC L01CX

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedabnobaVISCUM Fraxini 0,2 mg, anthropo…ATCL01CXREGISTER NO.68315003PACKS LISTED0CHECKEDJune 26, 2026

The record

At a glance

Manufacturer
Future Health Pharma GmbH
Country
Switzerland (CH)
ATC code
L01CX
ATC class
Other plant alkaloids and natural products
Swissmedic category
A
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/76a6dd37-ee48-40c3-9ed0-7107cd26ad6e
GET /v1/drugs/76a6dd37-ee48-40c3-9ed0-7107cd26ad6e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Anthroposophische Arzneimittel"
}

See everything about abnobaVISCUM.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.